Eve Fryer
Overview
Explore the profile of Eve Fryer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta T, Antanaviciute A, Hyun-Jung Lee C, Ottakandathil Babu R, Aulicino A, Christoforidou Z, et al.
Cancer Cell
. 2024 May;
42(5):797-814.e15.
PMID: 38744246
The success of checkpoint inhibitors (CPIs) for cancer has been tempered by immune-related adverse effects including colitis. CPI-induced colitis is hallmarked by expansion of resident mucosal IFNγ cytotoxic CD8 T ...
2.
Denholm J, Schreiber B, Jaeckle F, Wicks M, Benbow E, Bracey T, et al.
BMJ Open Gastroenterol
. 2024 Feb;
11(1).
PMID: 38302475
Objective: Coeliac disease (CD) diagnosis generally depends on histological examination of duodenal biopsies. We present the first study analysing the concordance in examination of duodenal biopsies using digitised whole-slide images...
3.
Browning L, White K, Siiankoski D, Colling R, Roskell D, Fryer E, et al.
Front Med (Lausanne)
. 2022 Aug;
9:933933.
PMID: 35979219
Digital pathology (DP) offers potential for time efficiency gains over an analog workflow however, to date, evidence supporting this claim is relatively lacking. Studies available concentrate on specific workflow points...
4.
Browning L, Winter L, Cooper R, Ghosh A, Dytor T, Colling R, et al.
J Clin Pathol
. 2022 Jul;
76(10):712-718.
PMID: 35906044
Aims: With increasing utility of digital pathology (DP), it is important to consider the experiences of histopathologists in training, particularly in view of the varied access to DP across a...
5.
Sasson S, Slevin S, Cheung V, Nassiri I, Olsson-Brown A, Fryer E, et al.
Gastroenterology
. 2021 Jun;
161(4):1229-1244.e9.
PMID: 34147519
Background & Aims: The pathogenesis of immune checkpoint inhibitor (ICI)-colitis remains incompletely understood. We sought to identify key cellular drivers of ICI-colitis and their similarities to idiopathic ulcerative colitis, and...
6.
Imajo K, Tetlow L, Dennis A, Shumbayawonda E, Mouchti S, Kendall T, et al.
World J Gastroenterol
. 2021 Mar;
27(7):609-623.
PMID: 33642832
Background: Non-invasive assessment of non-alcoholic steatohepatitis (NASH) is increasing in desirability due to the invasive nature and costs associated with the current form of assessment; liver biopsy. Quantitative multiparametric magnetic...
7.
Peters R, Martin H, Virdee A, Fryer E, Bungay H, Rodriguez-Justo M, et al.
Ann Rheum Dis
. 2020 Nov;
82(9):e210.
PMID: 33148699
No abstract available.
8.
Pell R, Fryer E, Manek S, Winter L, Roberts I
Lancet Public Health
. 2020 Aug;
5(9):e474.
PMID: 32791050
No abstract available.
9.
Browning L, Fryer E, Roskell D, White K, Colling R, Rittscher J, et al.
J Clin Pathol
. 2020 Jul;
74(2):129-132.
PMID: 32616541
The COVID-19 pandemic has challenged our diagnostic services at a time when many histopathology departments already faced a diminishing workforce and increasing workload. Digital pathology (DP) has been hailed as...
10.
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
Cheung V, Gupta T, Olsson-Brown A, Subramanian S, Sasson S, Heseltine J, et al.
Br J Cancer
. 2020 May;
123(2):207-215.
PMID: 32418993
Background: Immune checkpoint inhibitors (ICI) improve survival but cause immune-related adverse events (irAE). We sought to determine if CTCAE classification, IBD biomarkers/endoscopic/histological scores correlate with irAE colitis outcomes. Methods: A...